Blueprint Medicines (BPMC) News Today $101.52 -1.55 (-1.50%) Closing price 03:59 PM EasternExtended Trading$101.28 -0.23 (-0.23%) As of 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BPMC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Blueprint Medicines (NASDAQ:BPMC) Trading 6.2% Higher - Time to Buy?Blueprint Medicines (NASDAQ:BPMC) Trading Up 6.2% - Still a Buy?May 30 at 2:31 PM | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Director Jeffrey W. Albers Sells 5,000 SharesMay 30 at 7:37 AM | insidertrades.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 12,035 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 5.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 239,May 29 at 4:30 AM | marketbeat.comJefferies Financial Group Inc. Sells 6,623 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Jefferies Financial Group Inc. lessened its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 12.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 47,500 shares of the biotechnology company's stMay 28 at 6:03 AM | marketbeat.comZacks Research Issues Positive Outlook for BPMC EarningsMay 27 at 1:43 AM | americanbankingnews.comZacks Research Issues Positive Forecast for BPMC EarningsBlueprint Medicines Co. (NASDAQ:BPMC - Free Report) - Zacks Research increased their Q2 2025 earnings per share estimates for Blueprint Medicines in a research note issued to investors on Wednesday, May 21st. Zacks Research analyst A. Chakraborty now anticipates that the biotechnology company wilMay 27 at 1:35 AM | marketbeat.comLazard Asset Management LLC Has $118,000 Stock Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)Lazard Asset Management LLC cut its position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 86.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,378 shares of the biotechnology company's stock after selling 8,772 shares durinMay 26, 2025 | marketbeat.comZacks Research Analysts Increase Earnings Estimates for BPMCBlueprint Medicines Co. (NASDAQ:BPMC - Free Report) - Analysts at Zacks Research lifted their Q4 2026 earnings estimates for shares of Blueprint Medicines in a research report issued on Wednesday, May 21st. Zacks Research analyst A. Chakraborty now expects that the biotechnology company will postMay 25, 2025 | marketbeat.comVoloridge Investment Management LLC Sells 73,863 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Voloridge Investment Management LLC lessened its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 25.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 213,697 shares of the biotechnology company's stMay 25, 2025 | marketbeat.comZacks Research Analysts Lift Earnings Estimates for BPMCMay 25, 2025 | americanbankingnews.comProShare Advisors LLC Purchases 5,290 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)ProShare Advisors LLC grew its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 33.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,915 shares of the biotechnMay 24, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Purchased by Zimmer Partners LPZimmer Partners LP boosted its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 59.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,650 shares of the biotechnology company's stock aMay 23, 2025 | marketbeat.comNuveen Asset Management LLC Raises Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)Nuveen Asset Management LLC lifted its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 49.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 419,190 shares of the biotechnologMay 23, 2025 | marketbeat.comGotham Asset Management LLC Makes New $309,000 Investment in Blueprint Medicines Co. (NASDAQ:BPMC)Gotham Asset Management LLC bought a new stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 3,545 shares of the biotechnology compaMay 23, 2025 | marketbeat.comChristina Rossi Sells 2,274 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) StockMay 22, 2025 | insidertrades.comWoodline Partners LP Buys 86,614 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Woodline Partners LP grew its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 19.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 540,192 shares of the biotechnology company's stock after purchaMay 22, 2025 | marketbeat.comMan Group plc Decreases Stock Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)Man Group plc lowered its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 80.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 103,919 shares of the biotechnology company's stock afMay 21, 2025 | marketbeat.comTema Etfs LLC Invests $1.96 Million in Blueprint Medicines Co. (NASDAQ:BPMC)Tema Etfs LLC acquired a new position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 22,474 shares of the biotechnology company's stock, valued aMay 20, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by Rafferty Asset Management LLCRafferty Asset Management LLC reduced its position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 24.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,891 shares of the bioMay 20, 2025 | marketbeat.comPoint72 Asset Management L.P. Invests $14.52 Million in Blueprint Medicines Co. (NASDAQ:BPMC)Point72 Asset Management L.P. purchased a new position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 166,418 shares of the biotechnology company's stock, vaMay 20, 2025 | marketbeat.comCaptrust Financial Advisors Has $727,000 Stake in Blueprint Medicines Co. (NASDAQ:BPMC)Captrust Financial Advisors trimmed its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 53.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,331 shares of the biotechnology company's stock after selMay 20, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by Bank of America Corp DEBank of America Corp DE lessened its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 395,031 shares of the biotMay 19, 2025 | marketbeat.comPoint72 Europe London LLP Buys New Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)Point72 Europe London LLP bought a new stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 43,568 shares of the biotechnology company's stock, vMay 17, 2025 | marketbeat.comPolar Capital Holdings Plc Reduces Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)Polar Capital Holdings Plc lowered its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 28.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 626,379 shares of the biotechnology company's stock after sellinMay 17, 2025 | marketbeat.comProsight Management LP Increases Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)Prosight Management LP boosted its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 42.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 67,000 shares of the biotechnology company's stockMay 17, 2025 | marketbeat.comDeutsche Bank AG Grows Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)Deutsche Bank AG grew its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 9.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 261,363 shares of the biotechnology company's stockMay 17, 2025 | marketbeat.comAmeriprise Financial Inc. Purchases 13,501 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Ameriprise Financial Inc. raised its position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 4.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 338,115 shares of the biotechnology coMay 16, 2025 | marketbeat.comIntegral Health Asset Management LLC Sells 15,000 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Integral Health Asset Management LLC lowered its position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 5.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 275,000 shares of the biotechnology company's stock after selling 15,0May 14, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Acquires 152,573 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Jacobs Levy Equity Management Inc. raised its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 30.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 648,660 shares of the biotechnMay 14, 2025 | marketbeat.comGraham Capital Management L.P. Grows Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)Graham Capital Management L.P. lifted its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 48.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,260 shares of the biotechnology company's stockMay 14, 2025 | marketbeat.comEnsign Peak Advisors Inc Sells 50,722 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Ensign Peak Advisors Inc decreased its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 15.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 275,424 shares of the biotechnoMay 13, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Bought by Comerica BankComerica Bank grew its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 411.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 13,115 shares of the biotechnology company's stock after acquiring an additional 10May 13, 2025 | marketbeat.comGranahan Investment Management LLC Has $12.38 Million Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)Granahan Investment Management LLC grew its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 8.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 141,890 shares of the biotechnology company's stock after acquiring an additional 10May 12, 2025 | marketbeat.comFred Alger Management LLC Lowers Position in Blueprint Medicines Co. (NASDAQ:BPMC)Fred Alger Management LLC lowered its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 22.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,623 shares of the biotechnMay 12, 2025 | marketbeat.comFrontier Capital Management Co. LLC Grows Position in Blueprint Medicines Co. (NASDAQ:BPMC)Frontier Capital Management Co. LLC increased its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 401.6% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 105,130 shares of the biotechnology company's stock after buying an addMay 12, 2025 | marketbeat.comBalyasny Asset Management L.P. Purchases 48,736 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Balyasny Asset Management L.P. lifted its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 90.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 102,486 shares of the biotechnolMay 12, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Given Average Recommendation of "Moderate Buy" by AnalystsBlueprint Medicines Co. (NASDAQ:BPMC - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eighteen ratings firms that are covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation, thirteen have given a buy recommeMay 12, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) is DAFNA Capital Management LLC's 10th Largest PositionDAFNA Capital Management LLC grew its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 23.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 149,763 shares of the biotechnology company's stock after purchasing aMay 10, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Has $1.15 Million Position in Blueprint Medicines Co. (NASDAQ:BPMC)Schonfeld Strategic Advisors LLC cut its position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 77.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,200 shares of the biotechnology company's stock after selling 46,158 shareMay 10, 2025 | marketbeat.comNorthern Trust Corp Has $53.06 Million Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)Northern Trust Corp boosted its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 9.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 608,392 shares of the biotechnology comMay 10, 2025 | marketbeat.comBrevan Howard Capital Management LP Purchases 5,794 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Brevan Howard Capital Management LP boosted its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 48.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,751 shares of the biotechnologyMay 9, 2025 | marketbeat.comInsider Selling: Blueprint Medicines Co. (NASDAQ:BPMC) COO Sells 2,274 Shares of StockMay 8, 2025 | insidertrades.comAQR Capital Management LLC Grows Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)AQR Capital Management LLC increased its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 26.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 144,693 shares of the biotechnology company's stock after purchasing an additional 30,May 8, 2025 | marketbeat.comBrown Advisory Inc. Decreases Stock Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)Brown Advisory Inc. reduced its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 2.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 578,780 shares of the biotechnology company's stock after selling 14,988 shares during the quarteMay 7, 2025 | marketbeat.comBayesian Capital Management LP Makes New $1.62 Million Investment in Blueprint Medicines Co. (NASDAQ:BPMC)Bayesian Capital Management LP acquired a new stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 18,579 shares of the biotechnology company's stock, valued at approximaMay 7, 2025 | marketbeat.comBlueprint Medicines Is A Fast-Growing Small-Cap StockMay 7, 2025 | theglobeandmail.comAvidity Partners Management LP Sells 138,400 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Avidity Partners Management LP trimmed its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 43.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 176,600 shares of the biotechnology company's stockMay 6, 2025 | marketbeat.comAlgert Global LLC Raises Stake in Blueprint Medicines Co. (NASDAQ:BPMC)Algert Global LLC grew its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 21.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 112,172 shares of the biotechnology company's stock after purchasing an additionMay 6, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Acquires 26,488 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)The Manufacturers Life Insurance Company increased its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 17.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 176,484 shares of the biMay 6, 2025 | marketbeat.comAlkeon Capital Management LLC Acquires 81,700 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Alkeon Capital Management LLC boosted its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 11.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 800,628 shares of the biotecMay 5, 2025 | marketbeat.com Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address BPMC Media Mentions By Week BPMC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMC News Sentiment▼1.240.88▲Average Medical News Sentiment BPMC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMC Articles This Week▼188▲BPMC Articles Average Week Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ONC News Today BNTX News Today TEVA News Today SMMT News Today ITCI News Today GMAB News Today RDY News Today MRNA News Today ASND News Today VTRS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPMC) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s Next Move Could Shock Wall StreetIn just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Blueprint Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BPMC Stock Free BPMC Stock Alerts